Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics
- PMID: 27029948
- PMCID: PMC4815276
- DOI: 10.1186/s13287-016-0302-7
Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics
Abstract
Background: Adipose tissue is an attractive source of mesenchymal stem cells (MSC) as it is largely dispensable and readily accessible through minimally invasive procedures such as liposuction. Until recently MSC could only be isolated in a process involving ex-vivo culture and their in-vivo identity, location and frequency remained elusive. We have documented that pericytes (CD45-, CD146+, and CD34-) and adventitial cells (CD45-, CD146-, CD34+) (collectively termed perivascular stem cells or PSC) represent native ancestors of the MSC, and can be prospectively purified using fluorescence activated cell sorting (FACS). In this study we describe an optimized protocol that aims to deliver pure, viable and consistent yields of PSC from adipose tissue. We analysed the frequency of PSC within adipose tissue, and the effect of patient and procedure based variables on this yield.
Methods: Within this twin centre study we analysed the adipose tissue of n = 131 donors using flow cytometry to determine the frequency of PSC and correlate this with demographic and processing data such as age, sex, BMI and cold storage time of the tissue.
Results: The mean number of stromal vascular fraction (SVF) cells from 100 ml of lipoaspirate was 34.4 million. Within the SVF, mean cell viability was 83 %, with 31.6 % of cells being haematopoietic (CD45+). Adventitial cells and pericytes represented 33.0 % and 8 % of SVF cells respectively. Therefore, a 200 ml lipoaspirate would theoretically yield 23.2 million viable prospectively purified PSC - sufficient for many reconstructive and regenerative applications. Minimal changes were observed in respect to age, sex and BMI suggesting universal potential application.
Conclusions: Adipose tissue contains two anatomically and phenotypically discreet populations of MSC precursors - adventitial cells and pericytes - together referred to as perivascular stem cells (PSC). More than 9 million PSC per 100 ml of lipoaspirate can be rapidly purified to homogeneity using flow cytometry in clinically relevant numbers potentially circumventing the need for purification and expansion by culture prior to clinical use. The number and viability of PSC are minimally affected by patient age, sex, BMI or the storage time of the tissue, but the quality and consistency of yield can be significantly influenced by procedure based variables.
Keywords: Adipose tissue; Adipose-derived stem cell; Cell sorting; Flow cytometry; Mesenchymal stem cells; Pericyte; Tunica adventitia.
Figures
Similar articles
-
An abundant perivascular source of stem cells for bone tissue engineering.Stem Cells Transl Med. 2012 Sep;1(9):673-84. doi: 10.5966/sctm.2012-0053. Epub 2012 Sep 5. Stem Cells Transl Med. 2012. PMID: 23197874 Free PMC article.
-
Skeletogenic Capacity of Human Perivascular Stem Cells Obtained Via Magnetic-Activated Cell Sorting.Tissue Eng Part A. 2019 Dec;25(23-24):1658-1666. doi: 10.1089/ten.TEA.2019.0031. Epub 2019 Aug 16. Tissue Eng Part A. 2019. PMID: 31020920 Free PMC article.
-
Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering.Stem Cells Transl Med. 2012 Jun;1(6):510-9. doi: 10.5966/sctm.2012-0002. Epub 2012 Jun 11. Stem Cells Transl Med. 2012. PMID: 23197855 Free PMC article.
-
Perivascular cells for regenerative medicine.J Cell Mol Med. 2012 Dec;16(12):2851-60. doi: 10.1111/j.1582-4934.2012.01617.x. J Cell Mol Med. 2012. PMID: 22882758 Free PMC article. Review.
-
Adipose Tissue-Derived Pericytes for Cartilage Tissue Engineering.Curr Stem Cell Res Ther. 2017;12(6):513-521. doi: 10.2174/1574888X12666170321111211. Curr Stem Cell Res Ther. 2017. PMID: 28325151 Review.
Cited by
-
Adipose-derived Human Perivascular Stem Cells May Improve Achilles Tendon Healing in Rats.Clin Orthop Relat Res. 2018 Oct;476(10):2091-2100. doi: 10.1097/CORR.0000000000000461. Clin Orthop Relat Res. 2018. PMID: 30179944 Free PMC article.
-
On vasa vasorum: A history of advances in understanding the vessels of vessels.Sci Adv. 2022 Apr 22;8(16):eabl6364. doi: 10.1126/sciadv.abl6364. Epub 2022 Apr 20. Sci Adv. 2022. PMID: 35442731 Free PMC article. Review.
-
Effects of WNT3A and WNT16 on the Osteogenic and Adipogenic Differentiation of Perivascular Stem/Stromal Cells.Tissue Eng Part A. 2018 Jan;24(1-2):68-80. doi: 10.1089/ten.TEA.2016.0387. Epub 2017 May 22. Tissue Eng Part A. 2018. PMID: 28463594 Free PMC article.
-
Human perivascular stem cell-derived extracellular vesicles mediate bone repair.Elife. 2019 Sep 4;8:e48191. doi: 10.7554/eLife.48191. Elife. 2019. PMID: 31482845 Free PMC article.
-
Improving cartilage phenotype from differentiated pericytes in tunable peptide hydrogels.Sci Rep. 2017 Jul 31;7(1):6895. doi: 10.1038/s41598-017-07255-z. Sci Rep. 2017. PMID: 28761049 Free PMC article.
References
-
- Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403. - PubMed
-
- Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16(3):381–90. - PubMed
-
- Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17(4):331–40. doi: 10.1097/00007890-197404000-00001. - DOI - PubMed
-
- Caplan AI. Mesenchymal stem cells. J Orthop Res Wiley Online Library. 1991;9(5):641–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UM1 5UM1HL113457-04/HL/NHLBI NIH HHS/United States
- CAF/11/13/CSO_/Chief Scientist Office/United Kingdom
- MR/L022974/1/MRC_/Medical Research Council/United Kingdom
- MR/K017047/1/MRC_/Medical Research Council/United Kingdom
- UM1 HL113457/HL/NHLBI NIH HHS/United States
- 097483/WT_/Wellcome Trust/United Kingdom
- MR/L012766/1/MRC_/Medical Research Council/United Kingdom
- T32 HL079995/HL/NHLBI NIH HHS/United States
- MR/K026666/1/MRC_/Medical Research Council/United Kingdom
- 5T32HL079995-10/HL/NHLBI NIH HHS/United States
- R42775/BHF_/British Heart Foundation/United Kingdom
- G1000816/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
